IndexDefined Benefit Plan, Prescription Drug Benefit, Net Periodic Postretirement Benefit Cost, (Increase) Decrease for Subsidy
| Name | PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost1 |
|---|---|
| Namespace | http://fasb.org/us-gaap/2021-01-31 |
| Prefix | us-gaap |
| Data type | xbrli:monetaryItemType |
| Period type | duration |
| Substitution Group | xbrli:item |
| Balance | credit |
| Nillable | True |
| Abstract | False |
Labels
| Text | Lang | Role | Container role |
|---|---|---|---|
| Defined Benefit Plan, Prescription Drug Benefit, Net Periodic Postretirement Benefit Cost, (Increase) Decrease for Subsidy | en-US | http://www.xbrl.org/2003/role/label | http://www.xbrl.org/2003/role/link |
| Amount of (increase) decrease in net periodic benefit cost from government subsidy for prescription drug benefits. | en-US | http://www.xbrl.org/2003/role/documentation | http://www.xbrl.org/2003/role/link |
References
| Name | Value | Role |
|---|---|---|
| PublishDate | 2017-01 | http://fasb.org/us-gaap/role/tin/value |
| Positive_XBRL_Value | Decrease | http://fasb.org/us-gaap/role/tin/value |
| Negative_XBRL_Value | Increase | http://fasb.org/us-gaap/role/tin/value |
| elementCreationTaxonomyVersion | 2012 | http://fasb.org/us-gaap/role/tin/taxonomyImplementationNote |
| Publisher | FASB | http://www.xbrl.org/2003/role/disclosureRef |
| Name | Accounting Standards Codification | http://www.xbrl.org/2003/role/disclosureRef |
| Topic | 715 | http://www.xbrl.org/2003/role/disclosureRef |
| SubTopic | 60 | http://www.xbrl.org/2003/role/disclosureRef |
| Section | 50 | http://www.xbrl.org/2003/role/disclosureRef |
| Paragraph | 3 | http://www.xbrl.org/2003/role/disclosureRef |
| Subparagraph | (b) | http://www.xbrl.org/2003/role/disclosureRef |
| URI | http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964 | http://www.xbrl.org/2003/role/disclosureRef |